10x Genomics made $150.7 million last quarter, which was more than expected, and raised its yearly revenue forecast to $625 million to $635 million.

TXG · 10x Genomics

The AI's read

The smaller operating loss and higher gross margin show that more of each sales dollar remained after product costs. The company still expects 4%–6% sales growth after excluding revenue from patent agreements. That tempers the picture, but the improved results and raised forecast support a stronger view.